Department of Biochemistry and Biotechnology, Microbiology-Virology Laboratory, School of Health Sciences, University of Thessaly, Larissa, Greece.
University of Strasbourg, Ecole Superieure de Biotechnologie de Strasbourg, CNRS FRE 3211-Oncoprotein Group, Illkirch, France.
J Med Virol. 2015 Nov;87(11):1973-80. doi: 10.1002/jmv.24256. Epub 2015 May 19.
Integration of HPV16 DNA into the host chromosome usually disrupts the E1 and/or E2 genes. The present study investigated the disruption of E1, E2 genes in a total of eighty four HPV16-positive precancerous and cervical cancer specimens derived from Greek women (seventeen paraffin-embedded cervical biopsies and sixty seven Thin Prep samples). Complete E2 and E1 genes were amplified using three and nine overlapping primer sets respectively, in order to define the sites of disruption. Extensive mapping analysis revealed that disruption/deletion events within E2 gene occurred in high grade and cervical cancer samples (x(2) test, P < 0.01), while no evidence of E2 gene disruption was documented among low grade cervical intraepithelial neoplasias. In addition, disruptions within the E1 gene occur both in high and low grade cervical intraepithelial neoplasia. This leads to the assumption that in low grade cervical intraepithelial neoplasias only E1 gene disruption was involved (Fisher's exact test, P < 0.05), while in high grade malignancies and cervical cancer cases deletions in both E1 and E2 genes occurred. Furthermore, the most prevalent site of disruption of E1 gene was located between nucleotides 1059 and 1323, while the most prevalent deleted region of the E2 gene was located between nucleotides 3172 and 3649 (E2 hinge region). Therefore, it is proposed that each population has its own profile of frequencies and sites of disruptions and extensive mapping analysis of E1 and E2 genes is mandatory in order to determine suitable markers for HPV16 DNA integration analysis in distinct populations.
HPV16 病毒 DNA 整合到宿主染色体中通常会破坏 E1 和/或 E2 基因。本研究共检测了 84 例源自希腊女性的 HPV16 阳性癌前病变和宫颈癌标本(17 例石蜡包埋宫颈活检和 67 例 Thin Prep 样本)中 E1 和 E2 基因的破坏情况。使用三套和九套重叠引物分别扩增完整的 E2 和 E1 基因,以确定破坏的部位。广泛的图谱分析显示,E2 基因内的破坏/缺失事件发生在高级别和宫颈癌样本中(x(2)检验,P<0.01),而在低级别宫颈上皮内瘤变中没有发现 E2 基因破坏的证据。此外,E1 基因内的破坏也发生在高级别和低级别宫颈上皮内瘤变中。这使得人们假设在低级别宫颈上皮内瘤变中只涉及 E1 基因破坏(Fisher 确切检验,P<0.05),而在高级别恶性肿瘤和宫颈癌病例中,E1 和 E2 基因都发生了缺失。此外,E1 基因破坏最常见的部位位于核苷酸 1059 和 1323 之间,而 E2 基因缺失最常见的部位位于核苷酸 3172 和 3649 之间(E2 铰链区)。因此,建议每个群体都有其自身的破坏频率和部位特征,需要对 E1 和 E2 基因进行广泛的图谱分析,以便确定适用于不同人群 HPV16 DNA 整合分析的合适标记。